Condition
ABO Incompatibility
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Enrolling By Invitation1
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05581745Not ApplicableRecruiting
A2 to O Lung Transplants
NCT07273448Enrolling By InvitationPrimary
Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation
NCT06921330Not ApplicableCompleted
White Cover & Massage Effects on Bilirubin and Phototherapy in ABO-Incompatible Newborns
NCT06502847Completed
The Role of Breastmilk and Serum Exosomes in Neonatal Jaundice Due to ABO Incompatibility
NCT00917007WithdrawnPrimary
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Showing all 5 trials